CA2400562C - Hybrid expression of neisserial proteins - Google Patents

Hybrid expression of neisserial proteins Download PDF

Info

Publication number
CA2400562C
CA2400562C CA2400562A CA2400562A CA2400562C CA 2400562 C CA2400562 C CA 2400562C CA 2400562 A CA2400562 A CA 2400562A CA 2400562 A CA2400562 A CA 2400562A CA 2400562 C CA2400562 C CA 2400562C
Authority
CA
Canada
Prior art keywords
ala
gly
thr
asp
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2400562A
Other languages
French (fr)
Other versions
CA2400562A1 (en
Inventor
Maria Beatrice Arico
Maurizio Comanducci
Cesira Galeotti
Vega Masignani
Marzia Monica Giuliani
Mariagrazia Pizza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics SRL
Original Assignee
Novartis Vaccines and Diagnostics SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0004695A priority Critical patent/GB0004695D0/en
Priority to GB0004695.3 priority
Priority to GB0027675.8 priority
Priority to GB0027675A priority patent/GB0027675D0/en
Application filed by Novartis Vaccines and Diagnostics SRL filed Critical Novartis Vaccines and Diagnostics SRL
Priority to PCT/IB2001/000420 priority patent/WO2001064920A2/en
Publication of CA2400562A1 publication Critical patent/CA2400562A1/en
Application granted granted Critical
Publication of CA2400562C publication Critical patent/CA2400562C/en
Application status is Expired - Fee Related legal-status Critical
Anticipated expiration legal-status Critical

Links